Palisade Bio
(NASDAQ) PALI
Palisade Bio Financials at a Glance
Market Cap
$354.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$24.15M
EPS (TTM)
-$1.07
P/E Ratio
-1.91
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$2.10
Volume
5,411,609.45
Open
$2.17
Price
$2.10
Volume
5,411,609.45
Open
$2.17
Previous Close
$2.08
Daily Range
$1.99 - $2.17
52-Week Range
$0.53 - $2.86
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$2.10
Volume
5,411,609.45
Open
$2.17
Previous Close
$2.08
Daily Range
$1.99 - $2.17
52-Week Range
$0.53 - $2.86
Estimated Earnings Date
Aug 10, 2026
PALI News
PALI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Palisade Bio
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
J. D. Finley
Website
www.palisadebio.comHeadquarters
Carlsbad, CA 92008, US
PALI Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-36.79%
Return on Capital
-13.95%
Return on Assets
-18.12%
Earnings Yield
-52.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$354.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
173.58M
Volume
5.41M
Avg. Volume
3.83M
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$26.49M
EBITDA
-$25.43M
Operating Cash Flow
-$12.40M
Capital Expenditure
$0.00
Free Cash Flow
-$12.40M
Cash & ST Invst.
$132.63M
Total Debt
$0.00
Palisade Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$354.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$44.26M
N/A
Employees
8
N/A
Net Income
-$9.60M
-330.5%
EBITDA
-$9.60M
-330.9%
Quarterly Fundamentals
Total Cash
$132.63M
+1734.4%
Total Debt
$0.00
-100.0%
Accounts Receivable
$9.00K
-88.5%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-18.12%
N/A
Return on Invested Capital
-20.75%
N/A
Free Cash Flow
-$3.89M
-66.7%
Operating Cash Flow
-$3.89M
-66.7%